Treatment of refractory MALT lymphoma by lenalidomide plus bendamustine
Sign Up to like & getrecommendations! Published in 2022 at "Medicine"
DOI: 10.1097/md.0000000000028938
Abstract: Abstract Rationale: Marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue (MALT lymphoma) has an indolent natural course and disseminates slowly. However, there is currently no consensus regarding the optimal treatment strategy for relapsed/refractory… read more here.
Keywords: malt lymphoma; lenalidomide bendamustine; refractory malt; malt ... See more keywords